| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |